Jardiance®
Treatment of adults with type 2 diabetes mellitus as an adjunct to diet and exercise.
Search
It is about saving lives Alexis Jaliquias feline blood bank
Veterinarian Alexis Jaliquias founded one of the first blood banks for cats in South America
Championing novel science
Dr. Vikas Mohan Sharma announces FDA fast-track designation for BI 1358894 as potential treatment for Borderline Personality Disorder.
Why today’s depression trials demand smart new approaches
Dr. Vikas Mohan Sharma announces the first of its kind decentralized clinical trial in depression
Fighting Negative KRAS Feedback
Boehringer Ingelheim scientists are directly targeting KRAS, blocking feedback and ultimately getting ahead of resistance by investigating pan-KRAS approaches. Article from Marco Hofmann
Collaboration to fight NCDs
70 percent of global deaths are attributable to NCDs and severely impacting on people in low- and middle-income countries. Help is desperately needed.
Conversations Beyond Type 2 Diabetes
Anne and Franc, who are living with T2D, explore what it means to live with their condition and its associated comorbidities.
Our Commitment
We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals.
Respimat media
Respimat media
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
Good business performance gives Boehringer Ingelheim tailwind for investment in R&D
COVID-19 General Q&A
COVID-19 General Q&A
Submit Your Opportunity
Information on how to submit a partnering opportunity direct to Boehringer Ingelheim’s Business Development & Licensing team
Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom
Boehringer Ingelheim inaugurates new milestone on its long-term commitment to the Kingdom
The power of our people
Diversity & Inclusion is an integral part of Boehringer Ingelheim's identity.
Our Partners Bioharmony
Chandra Ghose, Founder and CEO of Bioharmony Therapeutics, talks about the urgent need for developing new antimicrobials and the benefits of partnering with Boehringer Ingelheim.
100-year anniversary of BI in respiratory care
100-year anniversary of Boehringer Ingelheim in respiratory care
Eyes on Retina. The Podcast.
In this podcast series, we hear from a range of retinal experts involved in the care of people living with retinal diseases.
Our Partners Harvard
Brock Reeve, Executive Director of the Harvard Stem Cell Institute, talks about the importance of working together to tackle the challenge of fibrosis.
Empagliflozin Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy
Empagliflozin Phase III EMPA-KIDNEY trial will stop early due to clear positive efficacy in people with chronic kidney disease
German Ambassador inaugurates Boehringer Ingelheim new Cairo office
German Ambassador inaugurates Boehringer Ingelheim new Cairo office
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
2019 performance: stronger foundation to absorb global effects of COVID-19 pandemic
Lameness – a common problem in horses
The causes of lameness, and why there is a clear need for innovation and new treatment options.
Bringing Precision to Psychiatry
Dr. Hugh Marston and Dr. Vikas Mohan Sharma discuss how precision psychiatry can enable people living with mental health conditions to thrive.
Harold Heart and Dorothy Diabetes
People with type 2 diabetes are up to four times more likely to develop cardiovascular disease than people without diabetes.
Oncology
We are looking for new early-science collaborations and invite you to join our expanding community of innovation partners in oncology.